Clinical trials query results

From Health Canada


New search



Medical condition:
MALIGNANT PLEURAL MESOTHELIOMA
Medical condition:
ADULT FEMALE,ADULT MALE
Drug name:
RAD-IFN (NADOFARAGENE FIRADENOVEC)/ CELECOXIB/ GEMCITABINE
Protocol title:
A PHASE III, OPEN LABEL, RANDOMIZED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INTRAPLEURAL ADMINISTRATION OF ADENOVIRUS-DELIVERED INTERFERON ALPHA-2B (RAD-IFN) IN COMBINATION WITH CELECOXIB AND GEMCITABINE IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA
Sponsor name:
TRIZELL, LTD
Date of no objection letter:
2019-03-07
Control number:
224389
Trial status:
ONGOING
Date study started:
2019-12-12
Date modified: